We are experiencing 4 week turn-around time in review of submissions and resubmissions. We recommend commencing this process concurrently with your ethics submission and allowing at least 8 weeks for registration to be completed from date of first submission. We currently do not have the capacity to expedite reviews.

Note also there are delays to review of updates. We appreciate your patience.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR

Registration number
Ethics application status
Date submitted
Date registered
Date last updated
Type of registration
Prospectively registered

Titles & IDs
Public title
A Non-Therapeutic study to assess the Functionality of the Kona Renal Denervation System in Subjects Undergoing Diagnostic Angiography
Scientific title
A Non-Therapeutic Feasibility Pilot Study to Assess the Targeting and Tracking Functionality of the Kona Renal Denervation System in Subjects Undergoing Diagnostic Angiography
Secondary ID [1] 262877 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Hypertension 270606 0
Condition category
Condition code
Cardiovascular 270767 270767 0 0

Study type
Description of intervention(s) / exposure
The Kona Renal Denervation System (RDS) is a focused therapeutic ultrasound system designed to administer catheter-guided, focused therapeutic ultrasound treatments to the sympathetic nerve complex of the renal artery to induce renal neurolysis (i.e., coagulation of the sympathetic nerves that innervate the kidneys). This Pilot study is intented to test the targeting and tracking function of the device only. The therapy (dosing) system components will be disabled in this pilot study. This research study will add between 15 to 30 minutes to the scheduled diagnostic angiography.
Intervention code [1] 269246 0
Treatment: Devices
Comparator / control treatment
Control group

Primary outcome [1] 279463 0
Assess the device-patient interface and renal artery targeting and tracking capability of the Kona Renal Denervation System (RDS) in patients who are undergoing diagnostic angiography via ultrasound
Timepoint [1] 279463 0
The ultrasound takes approximatley 5 minutes, and will occur after the routine angiography, just after the insertion of the Kona targeting catherter.
Secondary outcome [1] 287693 0
Timepoint [1] 287693 0

Key inclusion criteria
a. Subject is at least 18 years of age.
b. Subject is scheduled to undergo elective, diagnostic angiography.
Minimum age
18 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
a. Subject has a body weight > 150 kilograms.
b. Subject is pregnant, nursing or intends to become pregnant during the trial period.
c. Subject is currently enrolled in other potentially confounding research.
d. Subject has any condition that, at the discretion of the investigator, would preclude participation in the trial.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?

Intervention assignment
Single group
Other design features
Not Applicable
Type of endpoint(s)
Statistical methods / analysis

Recruitment status
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 269714 0
Commercial sector/Industry
Name [1] 269714 0
KONA Medical Inc.
Address [1] 269714 0
2495 140th Ave NE, Suite D100
Bellevue, WA 98005
Country [1] 269714 0
United States of America
Primary sponsor type
Commercial sector/Industry
Pacific Clinical Research Group
Suite G03, 1 Cassins Ave
North Sydney, NSW 2060
Secondary sponsor category [1] 268754 0
Name [1] 268754 0
Address [1] 268754 0
Country [1] 268754 0

Ethics approval
Ethics application status
Ethics committee name [1] 271679 0
St Vincent's Hospital (Melbourne) HREC-D
Ethics committee address [1] 271679 0
PO Box 2900
Fitzroy VIC 3065
Ethics committee country [1] 271679 0
Date submitted for ethics approval [1] 271679 0
Approval date [1] 271679 0
Ethics approval number [1] 271679 0

Brief summary
The purpose of this study is to research one aspect, the non-therapeutic targeting and tracking functionality, of the Kona Renal Denervation System. The research project is being conducted to gather information about how the system functions when placed in a clinical setting. Information gathered from this research project will be used for the development of the Kona Renal Denervation System.
Trial website
Trial related presentations / publications
Public notes

Principal investigator
Name 33045 0
Address 33045 0
Country 33045 0
Phone 33045 0
Fax 33045 0
Email 33045 0
Contact person for public queries
Name 16292 0
Anna Calleja
Address 16292 0
Project Manager
PO Box 1600
North Sydney NSW 2059
Country 16292 0
Phone 16292 0
+61 02 9925 4210
Fax 16292 0
Email 16292 0
Contact person for scientific queries
Name 7220 0
Thomas Anderson
Address 7220 0
Kona Medical Inc.
2495 140th Ave NE, Suite D100
Bellevue, WA 98005
Country 7220 0
United States of America
Phone 7220 0
+1 425 558 4616
Fax 7220 0
Email 7220 0

No information has been provided regarding IPD availability
Summary results
No Results